EDGAR Filing Documents for 0001104659-16-126412

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

SEC Accession No. 0001104659-16-126412

Filing Date

2016-06-09

Accepted

2016-06-09 16:30:58

Documents

Period of Report

2016-06-09

Document Format Files

Seq	Description	Document	Type	Size
1	6-K	a16-12745_26k.htm	6-K	15668
2	EX-99.1	a16-12745_2ex99d1.htm	EX-99.1	13505
3	GRAPHIC	g127452mmi001.jpg	GRAPHIC	3377
	Complete submission text file	0001104659-16-126412.txt		35033

Mailing Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053

Business Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053 (610) 254-9200

Strongbridge Biopharma plc (Filer) CIK: 0001634432 (see all company filings)

IRS No.: 981130690 | State of Incorp.: L2
Type: 6-K | Act: 34 | File No.: 001-37569 | Film No.: 161706335
SIC: 2834 Pharmaceutical Preparations